Long-Term Azithromycin Treatment in Pediatric Primary Ciliary Dyskinesia: A Retrospective Study

OBJECTIVES: Primary ciliary dyskinesia (PCD) is a rare genetic disease mainly involved in lung dysfunction. PCD patient outcomes after azithromycin (AZM) treatment have rarely been reported. This study was aimed to assess AZM treatment effects on disease progression of pediatric PCD patients. STUDY...

Descripción completa

Detalles Bibliográficos
Autores principales: Guan, Yuhong, Zhang, Xiang, Yang, Haiming, Xu, Hui, Zhao, Shunying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226474/
https://www.ncbi.nlm.nih.gov/pubmed/35757125
http://dx.doi.org/10.3389/fped.2022.905253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226474/
https://www.ncbi.nlm.nih.gov/pubmed/35757125
http://dx.doi.org/10.3389/fped.2022.905253

Ejemplares similares